当前位置:首页 - 行情中心 - 万泰生物(603392) - 财务分析

万泰生物

(603392)

  

流通市值:736.30亿  总市值:736.30亿
流通股本:12.65亿   总股本:12.65亿

万泰生物(603392)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-1.45亿元,每股收益-0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1230246.76万元,未分配利润708783.45万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1424050.61万元,负债193803.84万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入843,561,860.09400,625,153.872,245,403,245.651,948,111,396.63
营业总成本1,020,748,464.07464,970,086.222,395,621,317.621,928,979,981.89
其他经营收益
营业利润-139,343,509.3-55,796,443.4693,837,662.73264,472,673.64
利润总额-145,682,857.91-57,900,215.967,480,832.88246,152,310.63
净利润-145,492,229.78-54,141,986.42109,094,522.37270,486,136.27
每股收益
其他综合收益----
综合收益总额-145,492,229.78-54,141,986.42109,094,522.37270,486,136.27
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计7,902,103,469.57,629,260,1048,374,875,235.88,987,558,327.81
非流动资产:
非流动资产合计6,338,402,587.526,840,578,313.246,314,521,073.675,751,814,172.2
资产总计14,240,506,057.0214,469,838,417.2414,689,396,309.4714,739,372,500.01
流动负债:
流动负债合计1,726,115,381.981,844,366,705.742,012,071,700.241,949,090,950.55
非流动负债:
非流动负债合计211,923,039.05231,653,832.15229,364,743.46180,930,069.79
负债合计1,938,038,421.032,076,020,537.892,241,436,443.72,130,021,020.34
所有者权益(或股东权益):
归属于母公司股东权益合计12,118,763,891.6412,210,025,071.7512,262,802,018.6612,423,215,689.76
股东权益合计12,302,467,635.9912,393,817,879.3512,447,959,865.7712,609,351,479.67
负债和股东权益合计14,240,506,057.0214,469,838,417.2414,689,396,309.4714,739,372,500.01
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,169,621,581.5628,523,288.143,670,593,631.462,882,258,488.6
经营活动现金流出小计1,236,174,987.06714,496,218.83,315,511,984.772,684,463,229.33
经营活动产生的现金流量净额-66,553,405.56-85,972,930.66355,081,646.69197,795,259.27
投资活动产生的现金流量:
投资活动现金流入小计2,268,024,732.151,696,045,788.366,116,656,933.163,951,015,258.14
投资活动现金流出小计2,767,383,684.442,102,283,188.387,620,016,133.364,792,993,313.33
投资活动产生的现金流量净额-499,358,952.29-406,237,400.02-1,503,359,200.2-841,978,055.19
筹资活动产生的现金流量:
筹资活动现金流入小计120,598,537.5812,082.56309,450,248.08153,322,146.85
筹资活动现金流出小计167,381,109.6619,563,392.33922,193,669.99772,970,786.78
筹资活动产生的现金流量净额-46,782,572.16-18,751,309.77-612,743,421.91-619,648,639.93
汇率变动对现金及现金等价物的影响-891,741.35-233,920.664,384,996.85-3,469,849.79
现金及现金等价物净增加额-613,586,671.36-511,195,561.11-1,756,635,978.57-1,267,301,285.64
期末现金及现金等价物余额1,413,419,155.141,515,810,265.392,027,005,826.52,516,340,519.43
补充资料:
现金及现金等价物的净增加额-613,586,671.36--1,756,635,978.57-
TOP↑